Our top pick for
US stocks

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Universal Biosensors is a medical devices business based in Australia. Universal Biosensors shares (UBI) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Universal Biosensors has a trailing 12-month revenue of around $6 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
52-week range | $0.31 - $1.04 |
---|---|
50-day moving average | $0.54 |
200-day moving average | $0.7842 |
Target price | $1.13 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.077 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.355
1 month (2022-05-27) | -19.32% |
---|---|
3 months (2022-03-28) | -57.23% |
6 months (2021-12-24) | -60.56% |
1 year (2021-06-28) | -55.63% |
---|---|
2 years (2020-06-26) | 77.50% |
3 years (2019-06-28) | 63.22% |
Valuing Universal Biosensors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Universal Biosensors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Universal Biosensors's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $41.9 million (£0.0 million).
The EBITDA is a measure of a Universal Biosensors's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $6 million |
---|---|
Gross profit TTM | $2.1 million |
Return on assets TTM | -23.42% |
Return on equity TTM | -45.56% |
Profit margin | -228.64% |
Book value | 0.13 |
Market capitalisation | $59.4 million |
TTM: trailing 12 months
We're not expecting Universal Biosensors to pay a dividend over the next 12 months.
Over the last 12 months, Universal Biosensors's shares have ranged in value from as little as $0.31 up to $1.04. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Universal Biosensors's is 1.204. This would suggest that Universal Biosensors's shares are a little bit more volatile than the average for this exchange and represent, relatively speaking, a slightly higher risk (but potentially also market-beating returns).
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company primarily in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips; and distributes Siemens' Xprecia Stride Coagulation Analyzer, a test used to monitor the effect of the anticoagulant therapy warfarin. The company also manufactures and distributes Sentia SO2 test strips; and distributes Sentia Analyzer for the use in measurement of free SO2 levels in post-fermentation wine. In addition, it offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
Steps to owning and managing Kincora Copper shares.
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.